Cargando…

Dysosmobacter welbionis effects on glucose, lipid, and energy metabolism are associated with specific bioactive lipids

The newly identified bacterium Dysosmobacter welbionis J115(T) improves host metabolism in high-fat diet (HFD)-fed mice. To investigate mechanisms, we used targeted lipidomics to identify and quantify bioactive lipids produced by the bacterium in the culture medium, the colon, the brown adipose tiss...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moens de Hase, Emilie, Petitfils, Camille, Alhouayek, Mireille, Depommier, Clara, Le Faouder, Pauline, Delzenne, Nathalie M., Van Hul, Matthias, Muccioli, Giulio G., Cenac, Nicolas, Cani, Patrice D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542644/ https://www.ncbi.nlm.nih.gov/pubmed/37648213 http://dx.doi.org/10.1016/j.jlr.2023.100437

Ejemplares similares

Dysosmobacter welbionis is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice
por: Le Roy, Tiphaine, et al.
Publicado: (2022)

Chronic Endocannabinoid System Stimulation Induces Muscle Macrophage and Lipid Accumulation in Type 2 Diabetic Mice Independently of Metabolic Endotoxaemia
por: Geurts, Lucie, et al.
Publicado: (2013)

Gut Microbiota and Host Metabolism: From Proof of Concept to Therapeutic Intervention
por: Cani, Patrice D., et al.
Publicado: (2021)

Hepatic NAPE-PLD Is a Key Regulator of Liver Lipid Metabolism
por: Lefort, Charlotte, et al.
Publicado: (2020)

High-fat diet feeding differentially affects the development of inflammation in the central nervous system
por: Guillemot-Legris, Owein, et al.
Publicado: (2016)

Pasteurized Akkermansia muciniphila increases whole-body energy expenditure and fecal energy excretion in diet-induced obese mice
por: Depommier, Clara, et al.
Publicado: (2020)

Adipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota
por: Geurts, Lucie, et al.
Publicado: (2015)

A nanoparticle platform for combined mucosal healing and immunomodulation in inflammatory bowel disease treatment
por: Marotti, Valentina, et al.
Publicado: (2023)

Responses of Gut Microbiota and Glucose and Lipid Metabolism to Prebiotics in Genetic Obese and Diet-Induced Leptin-Resistant Mice
por: Everard, Amandine, et al.
Publicado: (2011)

From correlation to causality: the case of Subdoligranulum
por: Van Hul, Matthias, et al.
Publicado: (2020)

Inulin increases the beneficial effects of rhubarb supplementation on high-fat high-sugar diet-induced metabolic disorders in mice: impact on energy expenditure, brown adipose tissue activity, and microbiota
por: Régnier, Marion, et al.
Publicado: (2023)

Identification of new enterosynes using prebiotics: roles of bioactive lipids and mu-opioid receptor signalling in humans and mice
por: Abot, Anne, et al.
Publicado: (2021)

Dereplication and Quantification of Major Compounds of Convolvulus arvensis L. Extracts and Assessment of Their Effect on LPS-Activated J774 Macrophages
por: Abdul Khaliq, Hafiz, et al.
Publicado: (2022)

Hepatic MyD88 regulates liver inflammation by altering synthesis of oxysterols
por: Lefort, Charlotte, et al.
Publicado: (2019)

Novel insights into the genetically obese (ob/ob) and diabetic (db/db) mice: two sides of the same coin
por: Suriano, Francesco, et al.
Publicado: (2021)

The endocannabinoid system links gut microbiota to adipogenesis
por: Muccioli, Giulio G, et al.
Publicado: (2010)

Oxysterol levels and metabolism in the course of neuroinflammation: insights from in vitro and in vivo models
por: Mutemberezi, Valentin, et al.
Publicado: (2018)

Acetate: Friend or foe against breast tumour growth in the context of obesity?
por: Yelek, Caner, et al.
Publicado: (2020)

Effect of a methanolic extract of Salvadora oleoides Decne. on LPS-activated J774 macrophages, its in vitro and in vivo toxicity study and dereplication of its chemical constituents
por: Khaliq, Hafiz Abdul, et al.
Publicado: (2022)

miRNA profile is altered in a modified EAE mouse model of multiple sclerosis featuring cortical lesions
por: Orefice, Nicola S, et al.
Publicado: (2020)

Exploiting the biological effect exerted by lipid nanocapsules in non-alcoholic fatty liver disease
por: Domingues, Inês, et al.
Publicado: (2023)

The colonoscopic leakage model: a new model to study the intestinal wound healing at molecular level
por: Bachmann, Radu, et al.
Publicado: (2020)

Gut microbes participate in food preference alterations during obesity
por: de Wouters d’Oplinter, Alice, et al.
Publicado: (2021)

Polyunsaturated Fatty Acid Metabolism Signature in Ischemia Differs from Reperfusion in Mouse Intestine
por: Gobbetti, Thomas, et al.
Publicado: (2013)

Prebiotic oligofructose protects against high-fat diet-induced obesity by changing the gut microbiota, intestinal mucus production, glycosylation and secretion
por: Paone, Paola, et al.
Publicado: (2022)

Bioactive Lipids and Coronavirus
por: Yasri, Sora, et al.
Publicado: (2020)

Mediterranean diet, gut microbiota and health: when age and calories do not add up!
por: Cani, Patrice D, et al.
Publicado: (2020)

Targeting Carbohydrates and Polyphenols for a Healthy Microbiome and Healthy Weight
por: Van Hul, Matthias, et al.
Publicado: (2019)

Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism
por: Duparc, Thibaut, et al.
Publicado: (2017)

Lipids in Pathophysiology and Development of the Membrane Lipid Therapy: New Bioactive Lipids
por: Torres, Manuel, et al.
Publicado: (2021)

Obesity is associated with changes in oxysterol metabolism and levels in mice liver, hypothalamus, adipose tissue and plasma
por: Guillemot-Legris, Owein, et al.
Publicado: (2016)

A Lipidomics- and Transcriptomics-Based Analysis of the Intestine of Genetically Obese (ob/ob) and Diabetic (db/db) Mice: Links with Inflammation and Gut Microbiota
por: Suriano, Francesco, et al.
Publicado: (2023)

Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosis
por: Everard, Amandine, et al.
Publicado: (2019)

Bioactive Lipids in Health and Disease
por: Bari, Monica, et al.
Publicado: (2020)

Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome
por: Delzenne, Nathalie M, et al.
Publicado: (2011)

Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
por: Depommier, Clara, et al.
Publicado: (2019)

Serum metabolite profiling yields insights into health promoting effect of A. muciniphila in human volunteers with a metabolic syndrome
por: Depommier, Clara, et al.
Publicado: (2021)

Obese-associated gut microbes and derived phenolic metabolite as mediators of excessive motivation for food reward
por: de Wouters d’Oplinter, Alice, et al.
Publicado: (2023)

Rhubarb Supplementation Prevents Diet-Induced Obesity and Diabetes in Association with Increased Akkermansia muciniphila in Mice
por: Régnier, Marion, et al.
Publicado: (2020)

The Impact of Bioactive Lipids on Cardiovascular Development
por: Kleger, Alexander, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_00gqvapr3tel9es5e5mflev9um